CHAPTER VIII

PRELIMINARY WORKING BIBLIOGRAPHY

[1] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and

epidemiology of 2019 novel coronavirus: implications for virus origins and

receptor binding. Lancet. 2020;395(10224):565–74.

[2] Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus

from patients with pneumonia in China, 2019. N Engl J Med.

2020;382(8):727–33.

[3] Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of

pneumonia. Respirology. 2018;23(2):130–7.

[4] Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia

outbreak associated with a new coronavirus of probable bat origin. Nature.

2020. [Link] s41586-020-2012-7. 

[5] Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of

2019-nCoV in Italy: where they come from? J Med Virol. 2020:1–4.

[Link]

[6] Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos

G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus

(2019-nCoV) rejects the hypothesis of emergence as a result of a recent

recombination event. Infect Genet Evol. 2020;79:104212.

[7] Hampton T. Bats may be SARS reservoir. JAMA. 2005;294(18):2291.

[8] Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and

coronaviruses. Viruses. 2019;11(1):E41. [Link]

36
[9] Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural

reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676–9.

[10] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new

coronavirus associated with human respiratory disease in China. Nature.

2020. [Link]

[11] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical

characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.

[12] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics

of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia

in Wuhan, China. JAMA. 2020.

[13] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of

patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.

2020;395(10223):497–506.

[14] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological

and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia

in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.

[15] Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major

outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med.

2003;348(20):1986–94.

[16] Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-

Barrak A, et al. Epidemiological, demographic, and clinical characteristics of

47 cases of Middle East respiratory syndrome coronavirus disease from

Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–61.

37
[17] Wang H, Xiao X, Lu J, Chen Z, Li K, Liu H, et al. Factors associated with

clinical outcome in 25 patients with avian influenza a (H7N9) infection in

Guangzhou, China. BMC Infect Dis. 2016;16(1):534.

[18] Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical

characteristics of novel coronavirus cases in tertiary hospitals in Hubei

Province. Chin Med J. 2020. [Link]

[19] Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT

imaging features of 2019 novel coronavirus (2019-nCoV). Radiology.

2020;200230. [Link]

[20] Liu J, Liao X, Qian S et al. Community transmission of severe acute

respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect

Dis 2020 [Link]/10.3201/eid2606.200239

[21] Chan J, Yuan S, Kok K et al. A familial cluster of pneumonia associated

with the 2019 novel coronavirus indicating person-to-person transmission: a

study of a family cluster. Lancet 2020 doi: 10.1016/S0140-6736(20)30154-9

[22] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China,

of novel coronavirus-infected pneumonia. N Engl J Med 2020;

doi:10.1056/NEJMoa2001316.

[23] Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M,et

al. Active monitoring of persons exposed to patients with confirmed COVID-

19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep.

2020 doi : 10.15585/mmwr.mm6909e1external icon

38
[24] World Health Organization. Report of the WHO-China Joint Mission on

Coronavirus Disease 2019 (COVID-19) 16-24 February 2020 [Internet].

Geneva: World Health Organization; 2020 Available from:

[Link] source/coronaviruse/who-china-joint-

[Link]

[25] Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface

environmental, and personal protective equipment contamination by severe

acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic

patient. JAMA. 2020 Mar 4 [Epub ahead of print].

[26] Wang W, Xu Y, Ruqin G, et al. Detection of SARS-CoV-2 in Different

Types of Clinical Specimens. JAMA2020 doi:10.1001/jama.2020.3786.

[27] Lauer SA, Grantz KH, Bi Q et al. The Incubation Period of Coronavirus

Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases:

Estimation and Application. Ann Intern Med2020 doi: 10.7326/M20-0504.

[28] Liu Y, Yan LM, Wan L et al. Viral dynamics in mild and severe cases of

CVOID-19. Lancet Infect Dis [Link]/10.1016/S1473-3099(20)30232-2

[29] Wolfel R, Corman V, Guggemos W et al Virological assessment of

hospitalized cases of coronavirus disease 2019. doi:

10.1101/2020.03.05.20030502.

[30] Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with

the 2019 novel coronavirus indicating possible person-to-person transmission

during the incubation period. J Infect 2020 doi: 10.1093/jiaa077

39
[31] Huang R, Xia J, Chen Y, Shan C, Wu C. A family cluster of SARS-CoV-2

infection involving 11 patients in Nanjing, China Lancet Infect Dis 2020 doi:

10.1016/ S1473-3099(20)30147-X

[32] Pan X, Chen D, Xia Y et al. Asymptomatic cases in a family cluster with

SARS-CoV-2 infection. Lancet Infect Dis 2020 doi: 10.1016/ S1473-

3099(20)30114-6

[33] Tong Z-D, Tang A, Li K-F, Li P, Wang H-L, Yi J-P, et al. Potential

presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China,

2020. Emerg Infect Dis. 2020 doi: 10.3201/eid2605.200198

[34] Wei WE, Li Z, Chiew CJ, Yong SE, et al. Presymptomatic Transmission of

SARS-CoV-2 —Singapore, January 23–March 16, 2020. MMWR, 1 April

2020/69.

[35] Kimball A, Hatfield KM, Arons M, James A, et al. Asymptomatic and

Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care

Skilled Nursing Facility —King County, Washington, March 2020. MMWR, 3

April 2020, 69(13);377–381.

[36] World Meters, Covid-19 Coronavirus Pandemic, available at

[Link]

%20

[37] Barbera J, Macintyre A, Gostin L, Inglesby T, O'Toole T, DeAtley C, Tonat

K, Layton M: Large-Scale Quarantine Following Biological Terrorism in the

United States: Scientific Examination, Logistic and Legal Limits, and Possible

Consequences. JAMA. 2001, 286: 2711-2717. 10.1001/jama.286.21.2711.

40
[38] Reich DS: Modernizing local responses to public health emergencies:

Bioterrorism, epidemics, and the Model State Emergency Health Powers Act.

Journal of Contemporary Health Law and Policy. 2003, 19: 379-414.

[39] Lemon SM, Hamburg MA, Sparling PF, Choffnes ER, Mack A: Ethical and

legal considerations in mitigating pandemic disease: workshop summary.

2007, Washington, DC: Institute of Medicine. National Academy of Sciences

[40] Schabas R: Severe acute respiratory syndrome: Did quarantine help?.

Can J Infect Dis Med Microbiol. 2004, 15 (4): 204-

[41] Knobler S, Mahmoud A, Lemon S, Pray L, Eds: The Global Application of

Knowledge, Tools, and Technology: Opportunities and Obstacles. The Impact

of Globalization on Infectious Disease Emergence and Control: Exploring the

Consequences and Opportunities Workshop Report. 2006, Washington, DC:

Institute of Medicine, National Academy of Sciences, 80-124.

[42] Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP: Dynamically Modeling

SARS and Other Newly Emerging Respiratory Illnesses: Past, Present and

Future. Epidemiology. 2005, 16: 791-801.

10.1097/[Link].0000181633.80269.4c.

[43] Bensimon CM, Upshur RE: Evidence and effectiveness in decision making

for quarantine. American Journal of Public Health. 2007, 97: S44-S48.

10.2105/AJPH.2005.077305.

[44] R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al. Genomic

characterization and epidemiology of 2019 novel coronavirus: implications for

virus origins and receptor binding Lancet (2020).

41
[45] P. Zhou, X.L. Yang, X.G. Wang, B. Hu, L. Zhang, W. Zhang, et al.A

pneumonia outbreak associated with a new coronavirus of probable bat origin

Nature (2020).

[46] Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, et al. Early

transmission dynamics in Wuhan, China, of novel coronavirus-infected

pneumonia N Engl J Med, 382 (13) (2020), pp. 1199-1207

[47] W. Yu, G. Tang, L. Zhang, R. Corlett Decoding the evolution and

transmissions of the novel pneumonia coronavirus (SARS-CoV-2) using

whole genomic data ChinaXiv (2020)

[48] J.F. Chan, S. Yuan, K.H. Kok, K.K. To, H. Chu, J. Yang, et al.A familial

cluster of pneumonia associated with the 2019 novel coronavirus indicating

person-to-person transmission: a study of a family cluster Lancet (2020)

[49] A. Kramer, I. Schwebke, G. Kampf How long do nosocomial pathogens

persist on inanimate surfaces? A systematic review BMC Infect Dis, 6 (2006),

p. 130

[50] G. Kampf, D. Todt, S. Pfaender, E. Steinmann Persistence of

coronaviruses on inanimate surfaces and its inactivation with biocidal agents

J Hosp Infect (2020)

[51] C. Rothe, M. Schunk, P. Sothmann, G. Bretzel, G. Froeschl, C. Wallrauch,

et al. Transmission of 2019-nCoV infection from an asymptomatic contact in

Germany N Engl J Med (2020)

[52] K. Kupferschmidt Study claiming new coronavirus can be transmitted by

people without symptoms was flawed Science news (2020)

42
[53] C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al. Clinical features of

patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395

(10223) (2020), pp. 497-506

[54] D.K.W. Chu, Y. Pan, S.M.S. Cheng, K.P.Y. Hui, P. Krishnan, Y. Liu, et al.

Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak

of pneumonia Clin Chem (2020)

[55] Global surveillance for human infection with novel coronavirus (2019-

nCoV) World Health Organization (2020)

[56] C. Bauch, T. OrabyAssessing the pandemic potential of MERS-CoV

Lancet, 382 (9893) (2013), pp. 662-664

[57] S. Riley, C. Fraser, C.A. Donnelly, A.C. Ghani, L.J. Abu-Raddad, A.J.

Hedley, et al. Transmission dynamics of the etiological agent of SARS in

Hong Kong: impact of public health interventions Science, 300 (5627) (2003),

pp. 1961-1966

[58] Y. Yang, J.D. Sugimoto, M.E. Halloran, N.E. Basta, D.L. Chao, L. Matrajt,

et al. The transmissibility and control of pandemic influenza A (H1N1) virus

Science, 326 (5953) (2009), pp. 729-733

[59] Y. Liu, A. Gayle, A. Wilder-Smith JR. The reproductive number of COVID-

19 is higher compared to SARS coronavirus J Travel Med (2020),

10.1093/jtm/taaa021

[60] A. Kucharski, C. Althaus The role of super spreading in Middle East

respiratory syndrome coronavirus (MERS-CoV) transmission Euro Surveill, 20

(25) (2015) pii:21167

43
[61] H.E.A. Chen Clinical characteristics and intrauterine vertical transmission

potential of COVID-19 infection in nine pregnant women: a retrospective

review of medical records Lancet (2020), 10.1016/S0140-6736(20)30360-3

[62] D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, et al. Clinical

characteristics of 138 hospitalized patients with 2019 novel coronavirus-

infected pneumonia in Wuhan, China JAMA (2020)

[63] Y. Bai, L. Yao, T. Wei, F. Tian, D.Y. Jin, L. Chen, et al. Presumed

asymptomatic carrier transmission of COVID-19 JAMA (2020)

[64] Chang, M. Lin, L. Wei, L. Xie, G. Zhu, C.S. Dela Cruz, et al. Epidemiologic

and clinical characteristics of novel coronavirus infections involving 13

patients outside Wuhan, China JAMA (2020)

[65] N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, et al. Epidemiological

and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia

in Wuhan, China: a descriptive study Lancet (2020)

[66] W. Liu, Q. Zhang, J. Chen, R. Xiang, H. Song, S. Shu, et al. Detection of

Covid-19 in children in early January 2020 in Wuhan, China N Engl J Med,

382 (14) (2020), pp. 1370-1371

[67] J.F.-W. Chan, S. Yuan, K.-H. Kok, K.K.-W. To, H. Chu, J. Yang, et al.A

familial cluster of pneumonia associated with the 2019 novel coronavirus

indicating person-to-person transmission: a study of a family cluster Lancet

(2020)

[68] C.D.C. China, Epidemic update and risk assessment of 2019 novel

coronavirus Chinese Center for Diseases Control and Prevention (2020)

44
 [Link]

[accessed 18 May 2020]

[69] A. Patel, D.B. Jernigan, Initial public health response and interim clinical

guidance for the 2019 novel coronavirus outbreak—United States, December

31, 2019–February 4, 2020 ,MMWR Morb Mortal Wkly Rep, 69 (2020), p. 140

[70] J.W. Tang, P.A. Tambyah, D.S.C. Hui, Emergence of a novel coronavirus

causing respiratory illness from Wuhan, China J Infect (2020)

[71] P. Habibzadeh, E.K. StonemanThe novel coronavirus: a bird's eye view Int

J Occup Environ Med, 11 (2) (2020), pp. 65-71

[72] Organization WH Global surveillance for human infection with novel

coronavirus (2019-nCoV) (2020)

[73] C. Gidengil, A. Parker, B. Zikmund-Fisher, Trends in risk perceptions and

vaccination intentions: a longitudinal study of the first year of the H1N1

pandemic Am J Public Health, 102 (2012), pp. 672-679

[74] Organization WH, Clinical management of severe acute respiratory

infection when novel coronavirus (2019-nCoV) infection is suspected (2020)

[75] C. Russell, J. Millar, J. Baillie, Clinical evidence does not support

corticosteroid treatment for 2019-nCoV lung injury Lancet, 395 (10223)

(2020), pp. 473-475

[76] C.I. Paules, H.D. Marston, A.S. Fauci, Coronavirus infections – more than

just the common cold JAMA (2020)

45
[77] M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, et

al. First case of 2019 novel coronavirus in the United States N Engl J Med

(2020)

[78] Z. Wang, X. Chen, Y. Lu, F. Chen, W. Zhang, Clinical characteristics and

therapeutic procedure for four cases with 2019 novel coronavirus pneumonia

receiving combined Chinese and Western medicine treatment Biosci Trends

(2020)

[79] M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, et [Link] and

chloroquine effectively inhibit the recently emerged novel coronavirus (2019-

nCoV) in vitro Cell Res (2020)

[80] E. de Wit, F. Feldmann, J. Cronin, R. Jordan, A. Okumura, T. Thomas, et

al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus

macaque model of MERS-CoV infection Proc Natl Acad Sci USA, 3 (2020), p.

20192208

[81] X. Liu, X.-J. Wang, Potential inhibitors for 2019-nCoV coronavirus M

protease from clinically approved medicines bioRxiv (2020)

2020.2001.2029.924100

[82] H. Lu, Drug treatment options for the 2019-new coronavirus (2019-nCoV)

Biosci Trends (2020)

[83] World Health Organization (2012), Rapid Risk Assessment of Acute Public

Health Events, available at [Link]

/10665/70810/WHO_HSE_GAR_ARO_2012.1_eng.pdf?sequence=1

46